Cargando…
Individualized multimodal treatment strategy for anaplastic thyroid carcinoma—Case report of long-term remission and review of literature
INTRODUCTION: The prognosis of anaplastic thyroid cancer (ATC) is poor with a mean survival time of six months following diagnosis. Despite various attempts to modify common treatment modalities including surgery, external beam radiation and chemotherapy, an effective treatment is not available yet....
Autores principales: | Eckhardt, S., Hoffmann, S., Damanakis, A.I., Di Fazio, P., Pfestroff, A., Luster, M., Wunderlich, A., Bartsch, D.K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933033/ https://www.ncbi.nlm.nih.gov/pubmed/27379749 http://dx.doi.org/10.1016/j.ijscr.2016.06.013 |
Ejemplares similares
-
Individualised Multimodal Treatment Strategies for Anaplastic and Poorly Differentiated Thyroid Cancer
por: Wächter, Sabine, et al.
Publicado: (2018) -
Prostate-Specific Membrane Antigen in Anaplastic and Poorly Differentiated Thyroid Cancer—A New Diagnostic and Therapeutic Target?
por: Wächter, Sabine, et al.
Publicado: (2021) -
Anaplastic thyroid cancer: multimodal treatment results
por: Aslan, Zaki Antonio Taissoun, et al.
Publicado: (2014) -
Application of the American Thyroid Association Risk Assessment in Patients with Differentiated Thyroid Carcinoma in a German Population
por: Eilsberger, Friederike, et al.
Publicado: (2023) -
Mutation-based, short-term “neoadjuvant” treatment allows resectability in stage IVB and C anaplastic thyroid cancer
por: Maurer, Elisabeth, et al.
Publicado: (2023)